On October 17th, alternative data providers Nikkei and Nowcast joined the Eagle Alpha team to shed light on the current status, challenges, and solutions within the emerging Japanese alternative data market.
Michel Bohn, Chief Compliance Officer at Sensor Tower, and Anthony Bartolacci, Chief Strategy Officer, joined us and the Schulte Roth & Zabel team to discuss this topic.
On September 20th, 2023, two leading vendors, SpiderRock and NewMark Risk, delivered presentations on trends and developments in the world of options and discussed how new data sources can be used to augment investment processes.
On September 12, 2023, we hosted a client workshop titled "India's Data Protection Bill and What It Means For Alternative Data" which provides a thorough analysis of the evolving data privacy landscape in India. Below we provide the playback and highlight the key points discussed during the session.
On August 22nd, we were joined by Reyhan Ayas, Senior Economist at Revelio Labs, Josef Schmalfuss, Director at Oxford Data Plan, and Gershon Rossman, Director of Customer Success at PeerSpot to discuss the current tech landscape.
On August 15th, 2023, we were joined by Fable Data and Schulte Roth & Zabel to discuss the European transaction data landscape, in particular, the compliance challenges and best practices for vendors and buyers working with transaction data.
On July 27th, 2023, we held an interactive data webinar where quant and fundamental data providers discussed use cases and fresh features. We had representatives from seven different vendors: aiQ, ETF Global, Fable Data, Macrobond, Nowcast, Pronto NLP, and SpiderRock.
On July 25th, 2023, we were joined by Mysteel and Datago to discuss the potential of alternative data in shaping investment strategies, revealing hidden opportunities, and navigating potential challenges in emerging markets.
On July 18th, we were joined by Kaiko, Stockpulse, and SRZ to discuss alternative data and regulations in the crypto markets. As cryptocurrencies and associated transactions continue to proliferate, understanding the role and utility of alternative data becomes imperative.
On June 28th, Alexandre Templier, President of Quinten AI, delivered a presentation on how his firm works with real-world clinical data. This is part two of the session titled “AI and Real-world Data as a Strategic Opportunity for the Pharma Industry.
On June 28th, Christophe Fichet, Partner at Hughes Hubbard & Reed joined a client workshop discussing AI and real-world data as a strategic opportunity for the pharma industry.
On this month’s legal and compliance workshop, Dallán Ryan, Data Strategy Content and Advisory Lead was joined by Schulte Roth & Zabel to review ChatGPT compliance, DTCC and data degradation, SEC exams, and web scraping updates.
